Lochol and gait disturbance Patient Reports February 12, 2012
Lochol Side Effects Report #5936098-9
Lochol side effect was reported by a Physician from JAPAN on Oct 20, 2008. Male patient was diagnosed with transient ischaemic attack and was treated with Lochol. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, diarrhoea, enterocolitis, gait disturbance, malaise, muscular weakness, pyrexia. Lochol dosage: 30 MG/DAY. During the same period patient was treated with ANPLAG, PLETAL, BLOPRESS, MUCOSTA. Patient was hospitalized. Patient recovered.
Lochol Side Effects Report #5984372-2
Lochol side effect was reported by a Physician from JAPAN on Dec 02, 2008. Male patient was diagnosed with transient ischaemic attack and was treated with Lochol. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, diarrhoea, enterocolitis, gait disturbance, malaise, muscular weakness, pyrexia. Lochol dosage: 30 MG/DAY. During the same period patient was treated with ANPLAG, PLETAL, BLOPRESS, MUCOSTA. Patient was hospitalized. Patient recovered.
Lochol Side Effects Report #5293050-7
Lochol side effect was reported by a Pharmacist from JAPAN on Mar 27, 2007. Female patient, 79 years of age, was diagnosed with hypercholesterolaemia and was treated with Lochol. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cerebellar ataxia, gait disturbance, jaundice
, liver disorder, malaise. Lochol dosage: 10 MG/D. During the same period patient was treated with MERISLON, THYRADIN. Patient was hospitalized. Patient recovered.Lochol Side Effects Report #4854471-7
Lochol side effect was reported by a Physician from JAPAN on Nov 01, 2005. Female patient, 56 years of age, weighting 119.0 lb, was diagnosed with hypercholesterolaemia, hypertension, diabetes mellitus, thyroiditis chronic, asthma
, neurosis and was treated with Lochol. After drug was administered, patient experienced the following side effects: asthenia, basilar artery stenosis, brain stem infarction, dysarthria, gait disturbance, hemiparesis, hypoaesthesia, quadriplegia, sensory loss. Lochol dosage: 20 MG, QD. During the same period patient was treated with CONIEL, EUGLUCON, THYRADIN, UNIPHYL, PAXIL, MICARDIS, NORVASC. Patient was hospitalized and became disabled. Patient recovered.
Lochol and gait disturbance 